Identification of Correlates of Protection Against Shigella and Enterotoxigenic Escherichia Coli Infections
- Conditions
- Dysentery
- Interventions
- Other: Laboratory Tests
- Registration Number
- NCT01638039
- Lead Sponsor
- Hillel Yaffe Medical Center
- Brief Summary
The aim of this study is to accelerate the development of vaccine candidates against diarrheal diseases caused by Shigella and Enterotoxigenic Escherichia coli (ETEC). We plan to identify cases of laboratory-proven shigellosis and ETEC-associated diarrhea, to study humoral and cellular immune parameters following natural infections with Shigella and ETEC, and to compare the level of pre-existing local, humoral and cellular immune parameters in cases of shigellosis and ETEC-associated diarrhea and in matched controls.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 330
- Lab-confirmed Shigella or ETEC
- Individuals or patients without diarrheal disease
- n/a
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Diarrheal disease Laboratory Tests - Control Laboratory Tests Samples of stool, blood, urine saliva
- Primary Outcome Measures
Name Time Method Identification of cases of shigellosis and ETEC-associated diarrhea Four years Stool of patients examined in laboratory and identified as infected with the pathogens
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (7)
Edith Wolfson Medical Center
🇮🇱Holon, Israel
Emek Medical Center
🇮🇱Afula, Israel
Hillel Yaffe Medical Center
🇮🇱Hadera, Israel
Leumit Health Care System
🇮🇱Petach Tikvah, Elad, Israel
Lady Davis Carmel Medical Center
🇮🇱Haifa, Israel
Sansz Medical Center - Laniado Hospital
🇮🇱Netanya, Israel
Schneider Children's Medical Center
🇮🇱Petach Tikva, Israel